Scarica l'app Stockscreener
120.67
2.96%
-3.68
Dopo l'orario di chiusura:
120.59
-0.08
-0.07%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GILD Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Gilead Sciences Inc Borsa (GILD) Ultime notizie
Will Gilead Sciences Inc. stock attract ESG investorsJuly 2025 Technicals & Real-Time Buy Signal Notifications - ulpravda.ru
Gilead Names Wettan Executive Vice President - BioXconomy
Gilead (GILD) Recalls Veklury Due to Contaminant Concerns - GuruFocus
What is the fair value of Gilead Sciences Inc. stock now2025 Top Gainers & Risk Controlled Stock Alerts - ulpravda.ru
Gilead presents positive data on liver fibrosis treatments - The Pharma Letter
The Escalator: Argenx, Gilead Sciences, Bristol Myers Squibb and more - Medical Marketing and Media
Gilead Sciences, Inc. $GILD Holdings Decreased by Commonwealth Equity Services LLC - MarketBeat
Today's Analyst Action: Citigroup Raises Gilead Sciences (GILD) Price Target | GILD Stock News - GuruFocus
GSK/Ionis Partnered Investigational Drug Shows Strong Results In Large Hepatitis B Studies - Benzinga
UBS Raises Gilead Sciences (GILD) Price Target to $145 and Upgra - GuruFocus
Gilead Sciences (NASDAQ:GILD) Given Buy Rating at UBS Group - MarketBeat
Assessing Gilead Sciences (GILD) Valuation After Recent Share Price Momentum - Yahoo! Finance Canada
UBS raises Gilead Sciences stock price target to $145 on HIV drug outlook - Investing.com India
Gilead Sciences (NASDAQ:GILD) Nasdaq 100 Index Biopharma Scale - Kalkine Media
Key facts: Citi names Gilead Sciences a top biopharma pick; margin concerns rise - TradingView — Track All Markets
Assessing Gilead Sciences (GILD) Valuation After Mixed Near Term Returns And 9.4% Undervaluation Estimate - simplywall.st
Gilead Keeps Dealing With $300M OncoNano Drug Delivery Cancer Pact - BioSpace
OncoNano Medicine partners with Gilead to test drug delivery tech - Investing.com
OncoNano Medicine partners with Gilead to test drug delivery tech By Investing.com - Investing.com Canada
OncoNano Medicine Announces Research Collaboration with Gilead to Apply ON-BOARD™ Delivery Technology to Gilead’s Drug Candidate - Yahoo Finance
Robeco Institutional Asset Management B.V. Purchases 59,295 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences (GILD): Buy, Sell, or Hold Post Q3 Earnings? - Yahoo Finance
Gilead Sciences (GILD) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Repare Therapeutics Sells RP-3467 Cancer Program Assets to Gilead for Up to $30 Million - TipRanks
11,480 Shares in Gilead Sciences, Inc. $GILD Bought by TriaGen Wealth Management LLC - MarketBeat
Railway Pension Investments Ltd Purchases 42,200 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
The Truth About Gilead Sciences Inc (GILD): Hidden Giant or Boomer Stock Trap? - AD HOC NEWS
Gateway Investment Advisers LLC Raises Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
SteelPeak Wealth LLC Sells 94,279 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Purchased by Asset Management One Co. Ltd. - MarketBeat
Verity & Verity LLC Has $30.05 Million Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Stock Position Lifted by Allspring Global Investments Holdings LLC - MarketBeat
Gilead Sciences (NASDAQ:GILD) Upgraded to "Strong-Buy" at Wall Street Zen - MarketBeat
Former Gilead exec who oversaw $20B in drug sales takes global role at autoimmune disease company - The Business Journals
AbbVie, Gilead gift themselves clinical-stage cancer drugs via licensing deals - Fierce Biotech
Miracle Mile Advisors LLC Buys 25,117 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
CapWealth Advisors LLC Has $27.04 Million Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Bank Pictet & Cie Europe AG Boosts Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Here's How Much $1000 Invested In Gilead Sciences 15 Years Ago Would Be Worth Today - Sahm
Gilead Sciences Q3 EPS Forecast Raised by Zacks Research - MarketBeat
Morgan Stanley Expects Gilead Sciences (GILD) to Thrive as Biopharma Policy Uncertainties Fade in 2026 - Finviz
What's Driving the Market Sentiment Around Gilead Sciences Inc? - Benzinga
Los Angeles Capital Management LLC Purchases 1,223,895 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Lee Johnson Capital Management LLC Makes New Investment in Gilead Sciences, Inc. $GILD - MarketBeat
Ascent Group LLC Buys 11,926 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead (GILD) Reaches Pricing Agreement with US Government to Lower Drug Costs - Finviz
Why Gilead Sciences (GILD) Dipped More Than Broader Market Today - sharewise.com
Insider Sell: Daniel O'Day Sells 10,000 Shares of Gilead Sciences Inc (GILD) - GuruFocus
Gilead (GILD) reaches pricing agreement with US government to lower drug costs - MSN
Daniel Patrick O'day Sells 10,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock - MarketBeat
Gilead Sciences Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Diversified Trust Co Increases Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Abacus FCF Advisors LLC Reduces Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Is Gilead Sciences (GILD) An Affordable Healthcare Stocks to Invest In? - Insider Monkey
Gilead stock nudges up after Bernstein flags limited Medicaid pricing hit - ts2.tech
After 25 Years, Recurrent Genital Herpes Treatment Gains Corporate Partner - Vax-Before-Travel
November phase III successes led by HIV wins from Gilead, Merck - BioWorld MedTech
Bernstein reiterates Gilead Sciences stock rating, citing minimal Medicaid impact - Investing.com
Repare Therapeutics Signs Asset Purchase Agreement With Gilead Sciences - TradingView — Track All Markets
Liver Fibrosis Treatment Market Is Booming So Rapidly | Gilead Sciences, Inc., Merck & Co., Inc. - openPR.com
Sapient Capital LLC Sells 8,077 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Bought by E. Ohman J or Asset Management AB - MarketBeat
Gilead Sciences exercises option to license Assembly Biosciences Helicase-Primase Inhibitor programs for... - Medical Dialogues
Meyer Handelman Co. Has $38.56 Million Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Highland Capital Management LLC Invests $1.76 Million in Gilead Sciences, Inc. $GILD - MarketBeat
0.04%
3.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):